A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain.
Xiaohui GuoYang YuYongbo ZhangLi SunYufeng LiBing SongLi HangMasayuki BabaYosuke WasakiKunika KikumoriEmiko MurayamaPublished in: Pain and therapy (2024)
ClinicalTrials.gov identifier, NCT04094662.